Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient

Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib. Tumor lysis syndrome induced by low-dose steroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Ok, Jun, Dae Won, Tae, Hye Jin, Lee, Kang Nyeong, Lee, Hang Lak, Lee, Oh Young, Choi, Ho Soon, Yoon, Byung Chul, Hahm, Joon Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association for the Study of the Liver 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379202/
https://www.ncbi.nlm.nih.gov/pubmed/25834806
http://dx.doi.org/10.3350/cmh.2015.21.1.85

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379202/
https://www.ncbi.nlm.nih.gov/pubmed/25834806
http://dx.doi.org/10.3350/cmh.2015.21.1.85

Ejemplares similares